Evidence map›Paper›PMID 18287261›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2008

Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT.

Wellington K Hsu, Mandeep S Virk, Brian T Feeley, David B Stout, Arion F Chatziioannou, Jay R Lieberman

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wellington K HsuDepartment of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Mandeep S Virk
Brian T Feeley
David B Stout
Arion F Chatziioannou
Jay R Lieberman
University of California, Los Angeles · US

Funding

UCLA Imaging Resource for Mouse Cancer ModelsR24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PHELPS, MICHAEL E · 2001 to 2006
$4.3M
RANKL and BMPs in Prostate Cancer Induced Bone LesionsR01CA103039 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LIEBERMAN, JAY R. · 2003 to 2007
$1.7M
NCI NIH HHS R01 CA103039NCI NIH HHS R24 CA092865NCI NIH HHS R24CA92865
6 · The paper itself

Abstract

unlabelledThe combination of small-animal PET/CT scans and conventional imaging methods may enhance the evaluation of in vivo biologic interactions of murine models in the study of prostate cancer metastasis to bone.

methodsSmall-animal PET/CT scans using (18)F-fluoride ion and (18)F-FDG coregistered with high-resolution small-animal CT scans were used to longitudinally assess the formation of osteoblastic, osteolytic, and mixed lesions formed by human prostate cancer cell lines in a severe combined immunodeficient (SCID) mouse tibial injection model. These scans were correlated with plain radiographs, histomorphometry, and soft-tissue measurements.

resultsSmall-animal PET/CT scans were able to detect biologic activity of cells that induced an osteoblastic lesion 2 wk earlier than on plain radiographs. Furthermore, both the size and the activity of the lesions detected on PET/CT images significantly increased at each successive time point (P < 0.05). (18)F-FDG lesions strongly correlated with soft-tissue measurements, whereas (18)F-fluoride ion activity correlated with bone volume measured on histomorphometric analysis (P < 0.005). Osteolytic lesions were successfully quantified using small-animal CT, whereas lesion sizes measured on (18)F-FDG PET scans also strongly correlated with soft-tissue tumor burden (P < 0.05). In contrast, for mixed lesions, (18)F-fluoride ion and (18)F-FDG PET/CT scans detected only minimal activity.

conclusion(18)F-FDG and (18)F-fluoride ion PET/CT scans can be useful tools in characterizing pure osteolytic and osteoblastic lesions induced by human prostate cancer cell lines. The value of this technology needs further evaluation to determine whether these studies can be used effectively to detect more subtle responses to different treatment regimens in animal models.

Indexed as

Fluorine RadioisotopesFluorodeoxyglucose F18AnimalsCell Line, TumorDisease Models, AnimalHumansMaleMiceMice, SCIDOsteolysisProstatic NeoplasmsRadionuclide ImagingRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityTissue DistributionFluorine RadioisotopesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID18287261
PMCPMC2678960
OpenAlexW2168772771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.